At the request of Carasent AB (publ), company registration 559478-3440, Nasdaq Stockholm has assessed that Carasent AB (publ) fulfills Nasdaq Stockholm's listing requirements. Provided that Carasent AB (publ) fulfills the liquidity requirements first day of trading is expected to be December 9, 2024. The shares are currently traded on Oslo Børs.
As per today’s date the company has a total of 72,324,781 shares.
| Short name: | CARA | |||||||||
| ISIN code: | SE0023261599 | |||||||||
| Order book ID: | 374423 | |||||||||
| Number of shares to be listed: | 72,324,781 | |||||||||
| Clearing: | CCP Cleared | |||||||||
| Segment: | Small Cap | |||||||||
| Market segment: | STO Equities CCP / 182 | |||||||||
| Tick Size table: | MiFID II tick size table | |||||||||
| MIC: | XSTO | |||||||||
ICB Classification | ||||||||||
| Industry code: | 20 Health Care | |||||||||
| Supersector code: | 2010 Health Care | |||||||||
For further information concerning this exchange notice please contact Issuer Surveillance, telephone 46 8 405 60 00, or iss@nasdaq.com.
Nasdaq Stockholm AB